Proinsulin as the possible key in the pathogenesis of type 1 diabetes

Acta Endocrinologica

Volumn 5, Issue 2, 2009, Pages 233-249

  Ionescu Tirgoviste C ^a  

^a 'Prof NC Paulescu' National Institute of Diabetes Nutrition and Metabolic Diseases   (Romania)

Author keywords

Antigens; Immunogenetics; Proinsulin; T lymphocyte; T1DM

Indexed keywords

EID: 70549109783     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2009.233     Document Type: Editorial

References (91)

1. Ionescu-Tîrgoviste C, Cheta D, Popa E, Mincu I. Le role de l'obesité dans l'etiopathogenie du diabete sucre. Medecine et Nutrition 1976; 12:97-106.
2. Ionescu-Tîrgoviste C, Paterache E, Cheta D, Farcasiu E, Serafinceanu C, Mincu I. Epidemiology of diabetes in Bucharest. Diabetic Med 1994; 11:413-417.
3. Ionescu-Tîrgoviste C. Proposal for a new classification of diabetes mellitus. Rev Roum Med Int 1998; 36:121-134.
4. Ionescu-Tîrgoviste C, Guja C, Ionescu L, Farcasiu E. Type 1 Diabetes is not an age related disease. Diabetes 1999; 48[Suppl1]:A393 (Abstract).
5. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619-633.
6. Nerup J, Platz P, Anderson OO, Christy M, Lyngsoe J, Poulsen JE, Ryder LP, Nielsen LS, Thomsen M, Svejgaard A. HLA antigens and diabetes mellitus. Lancet 1974; 2:864-866.
7. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2(7892):1279-1283.
8. Huang SW, Maclaren NK. Insulin-dependent diabetes: a disease of autoaggression. Science 1976; 192(4234):64-66.
9. Eisenbarth GS. Type 1 diabetes: a chronic autoimmune disease. N Engl J Med 1984; 314:1360-1368.
10. Shojania KG, Burton EC. The vanishing nonforensic autopsy. N Engl J Med 2008; 358:873-875.
11. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987; 40:1-14.
12. Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM, Knight AM, Love JM, McAleer MA, Prins JB, Rodrigues N, Lathrop M, Pressey A, DeLarato NH, Peterson LB, Wicker LS. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 1991; 351:542-547.
13. Singal DP, Blajchman MA. Histocompatibility antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 1973; 22:429-432.
14. Cudworth A, Woodrow J. HL-A system and diabetes mellitus. Diabetes 1974; 24:345-349.
15. Todd JA, Bell JI, McDevitt HO. HLA-DQb gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329:599-604.
16. Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 2001; 10:2025-2037.
17. Julier C, Hyer RN, Davies J, Merlin F, Soularue P, Briant L, Cathelineau G, Deschamps I, Rotter JI, Froguel P, Boitard C, Bell JI, Lathrop GM. Insulin-IGF2 region encodes a gene implicated in HLADR4-dependent diabetes susceptibility. Nature 1991; 354:155-159.
18. Bain SC, Prins JB, Hearne CM, Rodrigues NR, Rowe BR, Pritchard LE, Ritchie RJ, Hall JR, Undlien DE, Ronningen KS, Dunger DB, Barnett AH, Todd JA. Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4 positive individuals. Nat Genet 1992; 2:212-215.
19. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Rønningen KS, Barnett AH, Bain SC, Todd JA. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9:284-292.
20. Barratt BJ, Payne F, Lowe CE, Hermann R, Healy BC, Harold D, Concannon P, Gharani N, McCarthy MI, Olavesen MG, McCormack R, Guja C, Ionescu-Tirgoviste C, Undlien DE, Ronningen KS, Gillespie KM, Tuomilehto-Wolf E, Tuomilehto J, Bennett ST, Clayton DG, Cordell HJ, Todd JA. Remapping the insulin gene/IDDM2 locus in type 1 diabetes. Diabetes 2004; 53:1884-1889.
21. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA. The CTLA-4 gene region of chromosome 2q33 is linked to and associated with type 1 diabetes. Hum Mol Genet 1996; 5:1073-1080.
22. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bing-ley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423:506-511.
23. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36:337-338.
24. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu-Tirgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA. Replication of an association between the lymphoid tyrosine phosphotase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004; 53:3020-3023.
25. Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA. Localisation of a type 1 diabetes locus in the IL2RA/CD25 region using tag single nucleotide polymorphisms. Am J Hum Genet 2005; 76:773-779.
26. European Consortium for IDDM Genome Studies. A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet 2001; 69:1301-1313.
27. Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SR and the Type 1 Diabetes Genetics Consortium. Type 1 Diabetes: Evidence for susceptibility loci from four genomewide linkage scans in 1,435 multiplex families. Diabetes 2005; 54:2995-3001.
28. Concannon P, Chen WM, Julier C, Morahan G, Akolkar B, Erlich HA, Hilner JE, Nerup J, Nierras C, Pociot F, Todd JA, Rich SS, Type 1 Diabetes Genetics Consortium. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009; 58:1018-1022.
29. Merriman TR, Cordell HJ, Eaves IA, Danoy PA, Coraddu F, Barber R, Cucca F, Broadley S, Sawcer S, Compston A, Wordsworth P, Shatford J, Laval S, Jirholt J, Holmdahl R, Theofilopoulos AN, Kono DH, Tuomilehto J, Tuomilehto-Wolf E, Buzzetti R, Marrosu MG, Undlien DE, Rønningen KS, Ionesco-Tirgoviste C, Shield JP, Pociot F, Nerup J, Jacob CO, Polychronakos C, Bain SC, Todd JA. Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes 2001; 50:184-194.
30. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, Guja C, Ionescu-Tirgoviste C, Widmer B, Dunger DB, Savage DA, Walker NM, Clayton DG, Todd JA. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006; 38:617-619.
31. Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, Glessner JT, Grabs R, Casalunovo T, Taback SP, Frackelton EC, Lawson ML, Robinson LJ, Skraban R, Lu Y, Chiavacci RM, Stanley CA, Kirsch SE, Rappaport EF, Orange JS, Monos DS, Devoto M, Qu HQ, Polychronakos C. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448:591-594.
32. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
33. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JHM, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B, Burren OS, Lam AAC, Ovington NR, Allen J, Adlem E, Leung H-T, Wallace C, Howson JMM, Guja C, Ionescu-Tîrgoviste C. Genetics of Type 1 Diabetes in Finland, Simmonds MJ, Heward JM, Gough SCL, Dunger DB, the Wellcome Trust Case Control Consortium, Wicker LS, Clayton DG. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39:857-864.
34. Cavener DR. Sleeping beauty, awake! Regulation of insulin gene expression by methylation of Histone H3. Diabetes 2009; 58:28-29.
35. Miao F, Smith DD, Zhang L, Min A, Feng W, Natarajan R. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 2008; 57: 3189-3198.
36. Deering TG, Ogihara T, Trace AP, Maier B, Mirmira RG. Methyl-transferase set 7/9 maintains transcription and euchromatin structure at islet enriched genes. Diabetes 2009; 58:185-193.
37. Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, Lowe CE, Cooper JD, Hulme JS, Vella A, Dahlman I, Lam AC, Nutland S, Walker NM, Twells RC, Todd JA. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet 2006; 7:20, pp. 1-12.
38. Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, Pura M, Bøe Wolff AS, Husebye ES, Lilic D, Ryan KR, Gennery AR, Cant AJ, Abinun M, Spickett GP, Arkwright PD, Denning D, Costigan C, Dominguez M, McConnell V, Willcox N, Meager A. Autoantibodies against type 1 interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2008; 93:4389-4397.
39. Awata T, Kawasaki E, Tanaka S, Ikegami H, Maruyama T, Shimada A, Nakanishi K, Kobayashi T, Iizuka H, Uga M, Kawabata Y, Kanazawa Y, Kurihara S, Osaki M, Katayama S. Japanese Study Group on Type 1 Diabetes Genetics. Association of type 1 diabetes with two loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J Clin Endocrinol Metab 2009; 94:231-235.
40. Bonifacio E, Mayr A, Knopff A, Ziegler AG. Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence. Diabetologia 2009; 52:185-192.
41. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29:267-274.
42. Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man: Macrophages, lymphocytes, and interferon-γ containing cells. J Pathol 1991; 165:97-103.
43. Filippi CM. von Herrath MG. Viral trigger for type 1 diabetes. Pros and Cons. Diabetes 2008; 57:2863-2871.
44. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999; 48:460-468.
45. Kuglin B, Gries FA, Kolb H. Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes 1988; 37:130-132.
46. Böhmer K, Keilacker H, Kuglin B, Hübinger A, Bertrams J, Gries FA, Kolb H. Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia 1991; 34:830-834.
47. Toma A, Laïka T, Haddouk S, Luce S, Briand JP, Camoin L, Connan F, Lambert M, CaillatZucman S, Carel JC, Muller S, Choppin J, Lemonnier F, Boitard C. Recognition of human proinsulin leader sequence by class I - restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes. Diabetes 2009; 58:394-402.
48. Ionescu-Tirgoviste C, Guja C. Proinsulin, proamylin and the beta cell endoplasmic reticulum: The key for the pathogenesis of different diabetes phenotypes. Proc Rom Acad Series B 2007; 2:113-139.
49. Ionescu-Tirgoviste C. Prolegomenon to the European constitution book of diabetes mellitus. Proc Rom Acad Series B, 2008; 3:179-213.
50. Kawasaki E, Uga M, Nakamura K et al. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 2008; 51:2299-2302.
51. Brodie GM, Wallberg M, Santamaria P, Wong FS, Green EA. β-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes. Diabetes 2008; 57:909-917.
52. Vogt FR Jr, Kyle RA. The secret lives of monoclonal B cells. NEJM 2009; 360:722-723.
53. Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. Cytokines and β-cell biology: from concept to clinical translation. Endocr Rev 2008; 29:334-350.
54. Jacobsen MLB, Ronn SG, Brunn C, Larsen CM, Eizirik DL, Mandrup-Poulsen T, Billestrup N. IL-1β induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells. Diabetologia 2009; 52:281-288.
55. Phillips B, Nylander K, Harnaha J, Machen J, Lakomy R, Styche A, Gillis K, Brown L, Lafreniere D, Gallo M, Knox J, Hogeland K, Trucco M, Giannoukakis N. A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes. Diabetes 2008; 57:1544-1555.
56. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358:221-229.
57. Oikarinen M, Tauriainen S, Honkanen T, Vuori K, Karhunen P, Vasama-Nolvi C, Oikarinen S, Verbeke C, Blair GE, Rantala I, Ilonen J, Simell O, Knip M, Hyöty H. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 2008; 51:1796-1802.
58. Ionescu-Tirgoviste C. For a new paradigm of diabetes. Rom J Intern Med 2007; 45:3-15.
59. Monti P, Heninger AK, Bonifacio E. Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus. Curr Diab Rep 2009; 9:113-118.
60. Roep BO. Islet autoreactive CD8 T-cells in type 1 diabetes licensed to kill? Diabetes 2008; 57: 1156-1157.
61. Van YH, Lee WH, Ortiz S., Lee MH, Qin HJ, Liu CP. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon -γ-producing T-cells without affecting Th17 cells. Diabetes 2009; 58:146-155.
62. Ionescu-Tîrgoviste C, Guja C, Ioacara S, Vladica M. Plasma proinsulin could be a marker of beta cell dysfunction in both type 2 and type 1 diabetes, Diabetic Med 2006; 23[Suppl.4]: 66-67 (Abstract).
63. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. First-degree relatives of patients with type 1 diabetes mellitus. Islet cell antibodies and abnormal insulin secretion. N Eng J Med 1985; 313:461-464.
64. Heaton DA, Millward BA, Gray P, Tun Y, Hales CN, Pyke DA, Leslie RD. Evidence of beta cell dysfunction which does not lead on to diabetes: a study of identical twins of insulin dependent diabetes. BMJ 1987; 294:145-146.
65. Hartling SG, Lindgren F., Dahlqvist G., Persson B, Binder C. Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes 1989; 38:1271-1274.
66. Truyen I, De Pauw P, Jørgensen PN, Van Schravendijk C, Ubani O, Decochez K, Vandemeulebroucke E, Weets I, Mao R, Pipeleers DG, Gorus FK; Belgian Diabetes Registry. Proinsulin levels and the proinsulin:C-peptide ratio complement autoantibody measurement or predicting type 1 diabetes. Diabetologia 2005; 48:2322-2329.
67. Rhodes CJ, Alarcon C. What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 1994; 43:511-517.
68. Ramachandran A, Snehalatha C, Satyavani K, Vijay V. Effects of genetic predisposition on proinsulin responses in Asian Indians. Diabetes Res Clin Pract 1998; 41: 71-77.
69. Røder ME, Dinesen B, Hartling SG, Houssa P, Vestergaard H, Sodoyez-Goffaux F, Binder C. Intact proinsulin and β-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care 1999; 22: 609-614.
70. Hanley AJG, D'Agostino RJr, Wagenknecht LE, Saad MF, Savage PJ, Bergman R, Haffner SM. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51:1263-1270.
71. Kronborg J, Johnsen SH, Njølstad I, Toft I, Eriksen BO, Jenssen T. Proinsulin: insulin and insulin: glucose ratios as predictors of carotid plaque growth: a population based 7 year follow-up of the Tromsø Study. Diabetologia 2007; 50:1607-1614.
72. Cheta D, Dumitrescu C, Georgescu M, Cocioabã G, Lichiardopol R, Stamoran M, IonescuTîrgoviste C, Pãunescu-Georgescu M, Mincu I. A study of the types of diabetes mellitus in first degree relatives of diabetic patients. Diabet&Metab 1990; 16:11-15.
73. Eftychi C, Howson JMM, Barratt B, Vella A, Payne F, Smyth DJ, Twells RCJ, Walker NM, Rance H, Tuomilehto-Wolf E, Tuomilehto J, Undlien DE, Rønningen KS, Guja C, Ionescu-Tîrgovitte C, Savage D, Todd JA. Analysis of the type 2 diabetes - associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes. Diabetes 2004; 53:870-873.
74. Field SF, Howson JM, Smyth DJ, Walker NM, Dunger DB, Todd JA. Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects. Diabetologia 2007; 50:212-213.
75. Field SF, Howson JM, Walker NM, Dunger DB, Todd JA. Analysis of the obesity gene FTO in 14,803 type 1 diabetes cases and controls. Diabetologia 2007; 50:2218-2220.
76. Qu H-Q, Grant SFA, Bradfield JP, Kim C, Frackelton E, Hakonarson H, Polychronakos C. Association analysis of type 2 diabetes loci in type 1 diabetes. Diabetes 2008; 57:1983-1986.
77. Huxtable SJ, Saker PJ, Haddad L, Walker M, Frayling TM, Levy JC, Hitman GA, O'Rahilly S, Hattersley AT, McCarthy MI. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and Type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. Diabetes 2000; 49:126-130.
78. Støy J, Edghill EL, Flanagan SE, Ye H, Paz VP, Pluzhnikov A, Below JE, Hayes MG, Cox NJ, Lipkind GM, Lipton RB, Greeley SA, Patch AM, Ellard S, Steiner DF, Hattersley AT, Philipson LH, Bell GI. Neonatal Diabetes International Collaborative Group. Insulin gene mutations as a cause of permanent neonatal diabetes Proc Nat Acad Sci USA 2007; 104:15040-15044.
79. Litherland SA. Immunopathogenic interaction of environmental triggers and genetic susceptibility in diabetes: is epigenetics the missing link? Diabetes 2008; 57:3184-3186.
80. Allen JS, Pang K, Skowera A, Ellis R, Rackham C, Lozanoska-Ochser B, Tree T, Leslie RD, Tremble JM, Dayan CM, Peakman M. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to t-cells through immune complex capture. Diabetes 2009; 58:138-145.
81. Tisch R, Wang B. Role of plasmacytoid dendritic cells in type 1 diabetes: Friend or foe? Diabetes 2009; 58:12-13.
82. Bottazzo GF, Mann JI, Thorogood M, Baum JD, Doniach D. Autoimmunity in juvenile diabetics and their families. BMJ 1978; 6131:165-168.
83. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-110.
84. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 2005; 48:2221-2228.
85. Pietropaolo M, Surhigh JM, Nelson PW, Eisenbarth GS. Primer: Immunity and Autoimmunity. Diabetes 2008; 57:2872-2882.
86. von Herrath M. Can we learn from viruses how to prevent type 1 diabetes?: The role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies. Diabetes 2009; 58:2-11.
87. Imagawa A, Hanafusa T, Tamura S, Moriwaki M, Itoh N, Yamamoto K, Iwahashi H, Yamagata K, Waguri M, Nanmo T, Uno S, Nakajima H, Namba M, Kawata S, Miyagawa JI, Matsuzawa Y. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 2001; 50:1269-1273.
88. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia 2001; 44:914-922.
89. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim HS, Lee IK, Bonner-Weir S. Selective beta cell loss and alpha-cell expansion in patients with Type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003; 88:2300-2308.
90. Meier JJ. Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 2008; 51:703-713.
91. Sosenko JM, Plamer JP, Rafkin-Mervis L, Krisher JP, Cuthbertson D, Matheson D, Skyler JS. Glucose and C-peptide changes in the perionset period of type 1 diabetes in the diabetes prevention trial-type 1. Diabetes Care 2008; 31:2188-2192.